PRAT reportedly activates the renin-angiotensin system in hypertensive and obese rabbits by applying physical pressure to the surrounding blood vessels, worsening obesity-related metabolic disorders such as hypertension, insulin resistance, and atherosclerosis [12]. The gene discussed is REN; the disease is obesity due to melanocortin 4 receptor deficiency.